Literature DB >> 2295696

Identification of two related markers for common acute lymphoblastic leukemia as heat shock proteins.

J R Strahler1, R Kuick, C Eckerskorn, F Lottspeich, B C Richardson, D A Fox, L M Stoolman, C A Hanson, D Nichols, H J Tueche.   

Abstract

By direct analysis of the polypeptide constituents of leukemic cells, we have previously detected several polypeptides that are restricted in their expression to acute lymphoblastic leukemia (ALL). In this study, we provide evidence that two polypeptides designated L2 and L4 are structurally related and represent novel markers for common ALL. Partial amino acid sequence analysis did not uncover differences between L2 and L4. The sequences obtained correspond to a previously cloned human gene designated hsp 27 that is expressed, following heat shock treatment, in a variety of cells. 32Pi incorporation studies indicate that L4 is an unphosphorylated form and L2 is a phosphorylated form of hsp27. The two forms were inducible by heat shock in leukemic and nonleukemic lymphoid cells. Thus, in acute leukemia, the common ALL subtype is uniquely characterized by the constitutive expression of a polypeptide that represents a major cellular phosphoprotein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2295696      PMCID: PMC296406          DOI: 10.1172/JCI114413

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

Review 1.  Differentiation-linked leukemogenesis in lymphocytes.

Authors:  M F Greaves
Journal:  Science       Date:  1986-11-07       Impact factor: 47.728

2.  The protein identification resource (PIR).

Authors:  D G George; W C Barker; L T Hunt
Journal:  Nucleic Acids Res       Date:  1986-01-10       Impact factor: 16.971

Review 3.  Immunologic markers in childhood acute lymphocytic leukemia.

Authors:  W M Crist; C E Grossi; D J Pullen; M D Cooper
Journal:  Semin Oncol       Date:  1985-06       Impact factor: 4.929

4.  Developmental control of the heat shock response in Xenopus.

Authors:  M Bienz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

5.  The 27,000 daltons stress proteins are phosphorylated by protein kinase C during the tumor promoter-mediated growth inhibition of human mammary carcinoma cells.

Authors:  R Regazzi; U Eppenberger; D Fabbro
Journal:  Biochem Biophys Res Commun       Date:  1988-04-15       Impact factor: 3.575

6.  Genetic variants detected among 106 lymphocyte polypeptides observed in two-dimensional gels.

Authors:  S M Hanash; L J Baier; D Welch; R Kuick; M Galteau
Journal:  Am J Hum Genet       Date:  1986-09       Impact factor: 11.025

7.  B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation.

Authors:  L M Nadler; S J Korsmeyer; K C Anderson; A W Boyd; B Slaughenhoupt; E Park; J Jensen; F Coral; R J Mayer; S E Sallan
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

8.  Expression of the major heat shock protein (hsp 70) family during early mouse embryo development.

Authors:  A C Hahnel; D J Gifford; J J Heikkila; G A Schultz
Journal:  Teratog Carcinog Mutagen       Date:  1986

9.  Evidence for intracellular association of the glucocorticoid receptor with the 90-kDa heat shock protein.

Authors:  K J Howard; C W Distelhorst
Journal:  J Biol Chem       Date:  1988-03-05       Impact factor: 5.157

10.  Phorbol ester, calcium ionophore, or serum added to quiescent rat embryo fibroblast cells all result in the elevated phosphorylation of two 28,000-dalton mammalian stress proteins.

Authors:  W J Welch
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

View more
  11 in total

1.  Highly resolving two-dimensional gels for protein sequencing.

Authors:  S M Hanash; J R Strahler; J V Neel; N Hailat; R Melhem; D Keim; X X Zhu; D Wagner; D A Gage; J T Watson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

2.  Clinical proteomics: present and future prospects.

Authors:  Nicole M Verrills
Journal:  Clin Biochem Rev       Date:  2006-05

3.  Expression of stress-response (heat-shock) protein 27 in human brain tumors: an immunohistochemical study.

Authors:  M Kato; F Herz; S Kato; A Hirano
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 4.  Heat shock protein 27: its potential role in vascular disease.

Authors:  Gordon Ferns; Sedigheh Shams; Shahida Shafi
Journal:  Int J Exp Pathol       Date:  2006-08       Impact factor: 1.925

5.  Induction of heat shock protein 27 by hydroxyurea and its relationship to experimental metastasis.

Authors:  A E Eskenazi; J Powers; J Pinkas; S Oesterreich; S A Fuqua; C N Frantz
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

6.  Data base analysis of protein expression patterns during T-cell ontogeny and activation.

Authors:  S M Hanash; J R Strahler; Y Chan; R Kuick; D Teichroew; J V Neel; N Hailat; D R Keim; J Gratiot-Deans; D Ungar
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

7.  Study of heat shock protein HSP90 alpha, HSP70, HSP27 mRNA expression in human acute leukemia cells.

Authors:  K Xiao; W Liu; S Qu; H Sun; J Tang
Journal:  J Tongji Med Univ       Date:  1996

8.  Chemical validation of a druggable site on Hsp27/HSPB1 using in silico solvent mapping and biophysical methods.

Authors:  Leah N Makley; Oleta T Johnson; Phani Ghanakota; Jennifer N Rauch; Delaney Osborn; Taia S Wu; Tomasz Cierpicki; Heather A Carlson; Jason E Gestwicki
Journal:  Bioorg Med Chem       Date:  2021-01-24       Impact factor: 3.641

9.  Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas.

Authors:  O S Soldes; R D Kuick; I A Thompson; S J Hughes; M B Orringer; M D Iannettoni; S M Hanash; D G Beer
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

10.  Comparative proteomics in acute myeloid leukemia.

Authors:  Magdalena Luczak; Maciej Kaźmierczak; Luiza Hadschuh; Krzysztof Lewandowski; Mieczysław Komarnicki; Marek Figlerowicz
Journal:  Contemp Oncol (Pozn)       Date:  2012-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.